Cipher Pharmaceuticals Reports Q1 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- Wall St edges up as AI enthusiasm eases worries over higher oil prices, yields
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil slides as US-Iran truce hopes outweigh Houthi attacks on Saudi Arabia
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- US and Iran discuss phased deal to reopen Hormuz and end US blockade, sources say
Cipher Pharma (CPHR) Misses Q1 EPS by 6c
May 5, 2016 9:42 AM EDTCipher Pharma (NASDAQ: CPHR) reported Q1 EPS of ($0.10), $0.06 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $10.72 million.
For earnings history and earnings-related data on Cipher Pharma (CPHR) click here.
... More